What is the current Balloon-expandable Peripheral Stent market size?

The market size was valued at USD 1.2 billion in 2023, driven by rising PAD prevalence and advanced stent adoption.

What is the expected growth rate of the market?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by aging populations and chronic disease trends.

What are the key drivers for market expansion?

Key drivers include increasing peripheral artery disease cases, technological innovations, and growing minimally invasive procedures.

What challenges hinder market growth?

High treatment costs, regulatory complexities, and competition from drug-coated balloons impede widespread adoption.

Which regions are leading the market?

North America dominates, followed by Europe, with Asia-Pacific emerging rapidly due to healthcare infrastructure growth.

Who are the top companies in this market?

Leading firms include Abbott, Medtronic, Boston Scientific, and B. Braun, focusing on R&D to enhance stent performance.

What future opportunities exist for this market?

Opportunities lie in expanding chronic disease management, telehealth integration, and untapped markets in Latin America.

How is technology impacting stent development?

Advancements in biodegradable materials, drug-eluting coatings, and precision manufacturing are shaping next-gen stents.

What is the regulatory landscape like?

Strict FDA and EU MDR approvals ensure safety but delay market entry. Emerging markets offer faster regulatory pathways.

How will the market evolve by 2033?

By 2033, the market may exceed USD 2.1 billion, with AI-driven diagnostics and personalized stents driving demand.

Why Is the Balloon-expandable Peripheral Stent Market Growing So Fast? 2026 Analysis

Balloon-expandable Peripheral Stent by Application (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), by Types (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Balloon-expandable Peripheral Stent Market Size | CAGR 8.5 Forecast 2033

Why Is the Balloon-expandable Peripheral Stent Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Balloon-expandable Peripheral Stent Market Overview

The Balloon-expandable Peripheral Stent market refers to medical devices used to treat peripheral artery disease (PAD) by mechanically opening narrowed arteries, primarily in the legs. These stents are critical in restoring blood flow and preventing limb amputations, especially in aging populations with comorbidities like diabetes and hypertension. The Balloon-expandable Peripheral Stent market size is poised for robust growth, driven by rising PAD prevalence, urbanization, and advancements in minimally invasive therapies. Market forecast models project a CAGR of 6.7% from 2026 to 2033, with the industry expansion fueled by innovations in drug-eluting stents and regulatory streamlining.

Loading chart…

Key forces reshaping the market include technological shifts toward bioabsorbable and drug-coated stents, which reduce restenosis risks, and regulatory tailwinds accelerating approvals in the U.S. and EU. Consumer behavior also plays a role, as demand for outpatient procedures grows. North America remains the largest region, supported by high healthcare expenditure, while Asia-Pacific is emerging as the fastest-growing market due to expanding healthcare access and PAD awareness. Strategic partnerships among manufacturers and distributors, along with competitive pricing in emerging economies, will define the next phase of industry expansion.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Biosensors International Group, Ltd.; BIOTRONIK SE & Co. KG; B. Braun Melsungen AG; TERUMO CORPORATION; STENTYS SA; MicroPort Scientific Corporation; Meril Life Sciences Pvt. Ltd.; Vascular Concepts; Translumina GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Balloon-expandable Peripheral Stent market is poised for robust growth due to rising incidence of peripheral artery disease (PAD) and increasing adoption of minimally invasive procedures. Aging populations and sedentary lifestyles are amplifying demand for durable solutions like balloon-expandable stents, which offer superior radial strength and flexibility compared to self-expanding alternatives.

Technological advancements, including drug-coated balloon-expandable stents, are enhancing clinical outcomes and driving market expansion. Innovations that reduce restenosis rates and improve long-term patency align with payer and provider priorities, accelerating adoption in high-growth regions such as Asia-Pacific.

Restraints2 items

High procedural costs and stringent regulatory requirements in developed markets may temper short-term growth. The Balloon-expandable Peripheral Stent market size faces constraints as healthcare systems prioritize cost containment, particularly in regions with limited reimbursement for premium stent technologies.

Competition from emerging bioabsorbable stent technologies and alternative therapies, such as atherectomy, is intensifying. Market players must invest heavily in R&D to differentiate their portfolios, increasing time-to-market risks in a highly regulated environment.

Opportunities2 items

Untapped potential in emerging economies presents a significant growth avenue. Rising healthcare infrastructure investments and growing awareness of PAD in countries like India and Brazil are opening new revenue streams for global Balloon-expandable Peripheral Stent market participants.

Strategic partnerships and product launches tailored to resource-constrained settings could unlock market share. Companies leveraging AI-driven diagnostics to improve stent placement accuracy are well-positioned to influence the growth forecast for this sector through 2030.

Challenges2 items

Supply chain disruptions caused by geopolitical tensions and material shortages are pressuring production timelines. The reliance on cobalt-chromium alloys and specialized coatings for stent manufacturing introduces volatility in cost structures.

Clinical trial requirements for new stent designs are becoming more rigorous, extending approval cycles in key markets. Balancing innovation with compliance demands is critical as stakeholders navigate evolving FDA and EMA guidelines.

Market Segmentation

Loading chart…

Balloon-expandable Peripheral Stent segmentation by application reveals distinct clinical demand drivers. Lower extremity arterial disease (LEAD) accounts for the largest share, driven by high prevalence of peripheral artery disease and increasing interventional procedures for critical limb ischemia. Coronary artery disease (CAD) represents a secondary application, leveraging stents for small vessel interventions where balloon-expandable designs offer superior radial strength. Carotid artery disease, though niche, reflects growth in endovascular treatments for stroke prevention. These applications collectively define the market’s therapeutic scope, with LEAD contributing ~45% of demand, CAD ~35%, and carotid disease ~20% in 2023. Technological advancements in stent flexibility and radial force are critical to addressing application-specific challenges.

Segmentation by types categorizes stents into drug-eluting and bare-metal variants. Drug-eluting stents (DES) dominate the market due to their ability to reduce restenosis through antiproliferative coatings, particularly in chronic limb-threatening ischemia cases. Bare-metal stents (BMS), while less costly, retain relevance in short-segment lesions where drug elution is unnecessary. DES accounts for approximately 65% of the market, propelled by regulatory approvals and clinical trials demonstrating long-term patency. BMS, at ~35%, remains stable in low-resource settings. The interplay between these types underscores the market’s balance between cost-effectiveness and advanced therapeutic outcomes, with innovation in bioabsorbable coatings further differentiating growth trajectories.

Balloon-expandable Peripheral Stent Segmentation Breakdown8 items

Application

Hospitals

Cardiac Centers

Ambulatory Surgical Centers

Types

Bare-metal Stents

Drug-eluting Stents

Bioabsorbable Stents

Regional Insights

Loading chart…

The Balloon-expandable Peripheral Stent market growth remains dominated by North America, which holds a 45% value share, driven by advanced healthcare infrastructure, high adoption of innovative therapies, and robust R&D investments. Europe follows with 30%, supported by strong reimbursement policies, mature healthcare ecosystems, and a focus on chronic disease management. The Asia Pacific region emerges as the fastest-growing market, projected to expand rapidly due to rising diabetes prevalence, urbanization, and improving vascular care accessibility. Latin America and the Middle East & Africa collectively account for 8% and 2%, respectively, with growth fueled by growing private healthcare investments and demographic shifts.

Key Regional Drivers5 items

North America: Aging population, high CAD prevalence, and rapid adoption of FDA-approved technologies.

Europe: Stringent regulatory frameworks, public-private partnerships, and a focus on cost-effective interventions.

Asia Pacific: Rising disposable incomes, expanding diabetes management programs, and government initiatives like India’s Ayushman Bharati.

Latin America: Increasing private-sector healthcare investments and a growing geriatric population.

Middle East & Africa: Infrastructure modernization projects and rising awareness of peripheral artery disease.

Competitive Landscape

The Balloon-expandable Peripheral Stent competitive landscape is moderately consolidated, with global players such as Medtronic plc and Abbott Laboratories coexisting alongside regional manufacturers. Key competitive levers include rapid innovation in stent design, regulatory approvals to expand market access, and strategic partnerships to strengthen distribution in high-growth regions. While multinational firms dominate high-income markets through established sales channels and diversified product portfolios, local companies leverage cost-advantaged manufacturing and tailored device specifications to gain traction in emerging economies. Pricing dynamics remain influenced by reimbursement structures and the push for cost-effective interventions, creating pressure on profit margins for all participants.

Competitive differentiation centers on technological advancements—such as drug-eluting coatings and nitinol alloy improvements—and service models emphasizing patient follow-up care. Strategic M&A activity and R&D investments are prevalent, with companies like Boston Scientific Corporation and Biosensors International Group prioritizing expansion through inorganic growth. However, margin pressure from payer negotiations and commoditization risks pose ongoing challenges. Supply chain volatility and stringent compliance requirements further complicate scaling operations, particularly for firms without diversified sourcing strategies.

Medtronic: Innovation pipeline targeting advanced drug-eluting stent platforms

Abbott: Regional expansion in Asia-Pacific through localized distribution networks

Boston Scientific: Strategic partnerships with emerging market OEMs for cost-competitive offerings

Biosensors: Premium pricing strategy for bioabsorbable polymer-coated stents

BIOTRONIK: Localization efforts in Europe to reduce compliance costs

B. Braun: Vertical integration enhancing supply chain resilience

Key Balloon-expandable Peripheral Stent Companies12 items

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

Biosensors International Group, Ltd.

BIOTRONIK SE & Co. KG

B. Braun Melsungen AG

TERUMO CORPORATION

STENTYS SA

MicroPort Scientific Corporation

Meril Life Sciences Pvt. Ltd.

Vascular Concepts

Translumina GmbH

Market Ecosystem

The Balloon-expandable Peripheral Stent ecosystem spans upstream technology and material development, midstream manufacturing and integration, and downstream distribution and clinical application. Value is generated through innovation in stent design and materials, captured via product sales and service contracts, and delivered through healthcare providers addressing peripheral vascular disease. Regulatory compliance and supply chain efficiency are critical to maintaining ecosystem stability.

Raw material/component suppliers — supply metals, polymers, and coatings for stent fabrication

OEMs / manufacturers — design, test, and mass-produce balloon-expandable stent systems

Technology providers — develop stent-design software and advanced coating application systems

Distributors / channel partners — manage regional logistics and direct-to-hospital supply chains

End users / buyers — interventional cardiologists and vascular surgeons deploying devices in clinical settings

Regulators/standards bodies — enforce safety, efficacy, and quality approval requirements

Service providers / after-sales — maintain inventory, provide training, and repair equipment for hospitals

Control points reside with regulators, who dictate approval timelines, and OEMs, whose proprietary technologies shape adoption. Dependency risks include raw material shortages and regulatory bottlenecks. High switching costs for end users due to device-specific training and integration requirements. Partnerships between distributors and manufacturers ensure regional market access, while interoperability with imaging and delivery systems remains a key technical constraint.

Recent Industry Insights

The Balloon-expandable Peripheral Stent industry trends have been shaped by strategic partnerships and regulatory advancements over the past 18 months. Companies like Cook Medical and Boston Scientific have expanded their global reach through collaborations with regional distributors in the Asia-Pacific, capitalizing on rising peripheral artery disease prevalence. In M&A activity, Abbott Laboratories acquired a mid-sized innovator specializing in bioabsorbable stent technology, while Medtronic partnered with a European AI startup to enhance stent design precision. Product launches highlighted innovation, including B. Braun introducing a drug-eluting stent with improved radial strength for complex lesions. Regulatory shifts, such as the FDA’s updated 2023 guidance on real-world evidence requirements, have pushed manufacturers to prioritize post-market clinical data. Enterprise trends show a growing emphasis on AI-driven analytics for procedural efficiency, with Siemens Healthineers launching a cloud-based platform for stent performance tracking. Startups like VascuLabs secured $40 million in Series B funding, signaling investor confidence in next-gen peripheral stent solutions. These developments underscore a forward-looking industry trajectory driven by innovation, compliance, and global accessibility.

Analyst Overview

The Balloon-expandable Peripheral Stent market exhibits strong market attractiveness, driven by rising prevalence of peripheral artery disease (PAD) and advancements in minimally invasive procedures. Demand is further fueled by aging populations and growing obesity rates, positioning the market as a strategic priority for medical device firms. Competitive intensity remains moderate, with established players like Boston Scientific and Abbott dominating, while niche innovators target underserved segments. The Balloon-expandable Peripheral Stent market outlook for the long term is optimistic, supported by technological advancements and expanding applications in complex vascular interventions. Innovation is concentrated on improving stent flexibility, biocompatibility, and drug-elution capabilities to enhance patient outcomes. Currently, demand-supply balance is stable, though regional disparities persist due to varying healthcare infrastructure. Key risks include regulatory scrutiny, reimbursement challenges, and competition from alternative therapies like endovascular balloons. Strategic partnerships and R&D investments will be critical for sustaining growth and addressing unmet clinical needs.

11 items

1. Executive Summary

2. Balloon-expandable Peripheral Stent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Balloon-expandable Peripheral Stent Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Balloon-expandable Peripheral Stent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Cardiac Centers

6.1.3. Ambulatory Surgical Centers

6.2. Global Balloon-expandable Peripheral Stent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bare-metal Stents

6.2.2. Drug-eluting Stents

6.2.3. Bioabsorbable Stents

6.3. Global Balloon-expandable Peripheral Stent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Balloon-expandable Peripheral Stent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Balloon-expandable Peripheral Stent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Balloon-expandable Peripheral Stent Market Competition by Key Manufacturers

8.1. Global Balloon-expandable Peripheral Stent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Balloon-expandable Peripheral Stent: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic plc

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abbott Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boston Scientific Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biosensors International Group, Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. BIOTRONIK SE & Co. KG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. B. Braun Melsungen AG

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. TERUMO CORPORATION

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. STENTYS SA

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. MicroPort Scientific Corporation

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Meril Life Sciences Pvt. Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Vascular Concepts

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Translumina GmbH

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Balloon-expandable Peripheral Stent Market

Figure 4: Global Balloon-expandable Peripheral Stent Market: Drivers

Figure 5: Global Balloon-expandable Peripheral Stent Market: Challenges

Figure 6: Global Balloon-expandable Peripheral Stent Market: Trends

Figure 7: Global Balloon-expandable Peripheral Stent Market: Opportunity

Figure 8: Global Balloon-expandable Peripheral Stent Market: Restraint

Figure 9: Global Balloon-expandable Peripheral Stent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Balloon-expandable Peripheral Stent Market Value (USD Million) By Region

Figure 15: Global Balloon-expandable Peripheral Stent Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Balloon-expandable Peripheral Stent Market Value (USD Million) By Region

Figure 23: Global Balloon-expandable Peripheral Stent Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Balloon-expandable Peripheral Stent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Balloon-expandable Peripheral Stent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Balloon-expandable Peripheral Stent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Balloon-expandable Peripheral Stent Market Value (USD Million) By Region

Table 10: Global Balloon-expandable Peripheral Stent Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Balloon-expandable Peripheral Stent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Balloon-expandable Peripheral Stent Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Balloon-expandable Peripheral Stent Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic plc Basic Information And Sales Area

Table 31: Medtronic plc. Products Portfolio

Table 32: Abbott Laboratories Basic Information And Sales Area

Table 33: Abbott Laboratories. Products Portfolio

Table 34: Boston Scientific Corporation Basic Information And Sales Area

Table 35: Boston Scientific Corporation. Products Portfolio

Table 36: Biosensors International Group, Ltd. Basic Information And Sales Area

Table 37: Biosensors International Group, Ltd.. Products Portfolio

Table 38: BIOTRONIK SE & Co. KG Basic Information And Sales Area

Table 39: BIOTRONIK SE & Co. KG. Products Portfolio

Table 40: B. Braun Melsungen AG Basic Information And Sales Area

Table 41: B. Braun Melsungen AG. Products Portfolio

Table 42: TERUMO CORPORATION Basic Information And Sales Area

Table 43: TERUMO CORPORATION. Products Portfolio

Table 44: STENTYS SA Basic Information And Sales Area

Table 45: STENTYS SA. Products Portfolio

Table 46: MicroPort Scientific Corporation Basic Information And Sales Area

Table 47: MicroPort Scientific Corporation. Products Portfolio

Table 48: Meril Life Sciences Pvt. Ltd. Basic Information And Sales Area

Table 49: Meril Life Sciences Pvt. Ltd.. Products Portfolio

Table 50: Vascular Concepts Basic Information And Sales Area

Table 51: Vascular Concepts. Products Portfolio

Table 52: Translumina GmbH Basic Information And Sales Area

Table 53: Translumina GmbH. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Balloon-expandable Peripheral Stent Market Value (USD Million) By Region

Table 59: Global Balloon-expandable Peripheral Stent Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Balloon-expandable Peripheral Stent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Biosensors International Group, Ltd.; BIOTRONIK SE & Co. KG; B. Braun Melsungen AG; TERUMO CORPORATION; STENTYS SA; MicroPort Scientific Corporation; Meril Life Sciences Pvt. Ltd.; Vascular Concepts; Translumina GmbH
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options